Acacia Research monetizes intellectual property by acquiring, licensing, and enforcing patent portfolios, and has also invested in operating companies. Revenue typically comes from licensing agreements, settlements, and related IP activities rather than selling a single consumer product. It serves patent owners, licensees, and investors seeking returns from IP assets and related corporate holdings.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 51.2 | — | -3.3 | — |
| Q3 2025 | 59.5 | — | -2.7 | — |
| Q4 2025 | 50.1 | — | 3.4 | — |
| Q1 2026 | 54.2 | — | -15.7 | — |
| Q2 2026 | 114.6 | 123.6% | 0.1 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Senseonics Holdings, Inc. (SENS), Fossil Group, Inc. (FOSL), Assembly Biosciences, Inc. (ASMB), DiaMedica Therapeutics Inc. (DMAC), AgomAb Therapeutics NV (AGMB), Citi Trends, Inc. (CTRN)